Isaac Bright
Chief Executive Officer at RubrYc Therapeutics, Inc.
Net worth: - $ as of 2024-04-29
Profile
Isaac J.
Bright founded RubrYc Therapeutics, Inc., where he worked as Secretary, Chief Executive & Financial Officer.
Dr. Bright also currently works at RubrYc Therapeutics, Inc., as Chief Executive Officer & Secretary.
Dr. Bright also formerly worked at Imagion Biosystems Ltd., as Chief Executive Officer from 2023 to 2024, ImaginAb, Inc., as Director, Biotheranostics, Inc., as Vice President-Corporate Development, Medtronic Ltd., as Principal, QuantaLife, Inc., as Principal, and Theriva Biologics, Inc., as Vice President-Corporate Development in 2016.
Dr. Bright received his undergraduate degree from Pepperdine University, Masters Business Admin degree from The Wharton School of the University of Pennsylvania, and doctorate degree from Stanford University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMAGION BIOSYSTEMS LTD.
-.--% | 2024-01-14 | 0 ( -.--% ) | - $ | 2024-04-29 |
Isaac Bright active positions
| Companies | Position | Start |
|---|---|---|
RubrYc Therapeutics, Inc.
 RubrYc Therapeutics, Inc. BiotechnologyHealth Technology RubrYc Therapeutics, Inc. develops antibody therapy applications. Its products include RubrYc Discovery Engine, through which people can decode protein interactions through the integration of data and biological science. The company was founded in 2017 and is headquartered in San Carlos, CA. | Chief Executive Officer | - |
Former positions of Isaac Bright
| Companies | Position | End |
|---|---|---|
| IMAGION BIOSYSTEMS LIMITED | Chief Executive Officer | 2024-01-14 |
RubrYc Therapeutics, Inc.
RubrYc Therapeutics, Inc. BiotechnologyHealth Technology RubrYc Therapeutics, Inc. develops antibody therapy applications. Its products include RubrYc Discovery Engine, through which people can decode protein interactions through the integration of data and biological science. The company was founded in 2017 and is headquartered in San Carlos, CA. | Chief Executive Officer | 2022-08-31 |
| THERIVA BIOLOGICS, INC. | Corporate Officer/Principal | 2016-10-31 |
ImaginAb, Inc.
 ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Director/Board Member | - |
QuantaLife, Inc.
 QuantaLife, Inc. Miscellaneous Commercial ServicesCommercial Services QuantaLife, Inc. operates as a biotechnology company. It develops and manufactures products based on nucleic acid testing concept for the life science research, clinical molecular diagnostics, personalized medical care and industrial markets. The company was founded by Kevin Dean Ness, Benjamin Hindson, Christopher T. Blisard and William Wayne Colston Jr. in 2008 and is headquartered in Boulder, CO. | Corporate Officer/Principal | - |
Training of Isaac Bright
| Pepperdine University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Stanford University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| THERIVA BIOLOGICS, INC. | Health Technology |
| IMAGION BIOSYSTEMS LIMITED | Health Technology |
| Private companies | 5 |
|---|---|
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
Medtronic Ltd.
 Medtronic Ltd. Medical SpecialtiesHealth Technology Medtronic Ltd. engages in the development and manufacturing of medical equipment for people with chronic disease. It offers products and therapies for cardiac rhythm disease management, neuromodulation, spinal and biologics, diabetes, cardiovascular, and ear, nose, and throat diseases. The company was founded by Earl E. Bakken and Palmer Hermundslie in 1949 and is headquartered in Watford, the United Kingdom. | Health Technology |
QuantaLife, Inc.
QuantaLife, Inc. Miscellaneous Commercial ServicesCommercial Services QuantaLife, Inc. operates as a biotechnology company. It develops and manufactures products based on nucleic acid testing concept for the life science research, clinical molecular diagnostics, personalized medical care and industrial markets. The company was founded by Kevin Dean Ness, Benjamin Hindson, Christopher T. Blisard and William Wayne Colston Jr. in 2008 and is headquartered in Boulder, CO. | Commercial Services |
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Health Technology |
RubrYc Therapeutics, Inc.
RubrYc Therapeutics, Inc. BiotechnologyHealth Technology RubrYc Therapeutics, Inc. develops antibody therapy applications. Its products include RubrYc Discovery Engine, through which people can decode protein interactions through the integration of data and biological science. The company was founded in 2017 and is headquartered in San Carlos, CA. | Health Technology |
- Stock Market
- Insiders
- Isaac Bright
